HLB Life Science Co. Ltd Cash Flow Quality Index
HLB Life Science Co. Ltd cash flow quality index. HLB Life Science Co. Ltd (067630) has a Cash Flow Quality Index of -5.16x as of December 2024. Operating cash flow of ₩-32.01 Billion is below net income of ₩6.21 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 067630 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of HLB Life Science Co. Ltd (2014–2024)
Cash flow quality index of HLB Life Science Co. Ltd from 2014 to 2024. Historical Cash Flow Quality Index for HLB Life Science Co. Ltd across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 067630 net asset quality score to measure how much of total assets are equity-financed.
HLB Life Science Co. Ltd Cash Flow Quality Index by Year (2014–2024)
HLB Life Science Co. Ltd cash flow quality index by year from 2014 to 2024. Year-by-year earnings quality comparison for HLB Life Science Co. Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of HLB Life Science Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -5.16x | ₩-32.01 Billion | ₩6.21 Billion | ▼ -13149.7% |
| 2017 | -0.04x | ₩-302.04 Million | ₩7.76 Billion | ▼ -100.5% |
| 2014 | 7.43x | ₩10.43 Billion | ₩1.40 Billion | — |